Sclerostin inhibition alleviates breast cancer–induced bone metastases and muscle weaknessEric Hesse, Hanna Taipaleenmäki|JCI Insight|2019Cited by 113
Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cellsHanna Taipaleenmäki, Jane B. Lian|Oncotarget|2016Cited by 87